Boston, MA, United States of America

Karuna Therapeutics, Inc.


USPTO Granted Patents = 7


Trademarks = 4

Forward Citations = 9

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Bruce Rehlaender (5 out of 6 patents)

silverMedal Aimesther Betancourt (5 out of 8 patents)

bronzeMedal Roch Thibert (5 out of 7 patents)

4 James Allen Monn (2 out of 35 patents)

5 Kevin Matthew Gardinier (1 out of 5 patents)

6 Clifford Adam Schlecht (1 out of 1 patent)

7 Dennis A Bennett (1 out of 1 patent)

8 Giorgio Attardo (1 out of 1 patent)

9 James E Audia (1 out of 99 patents)

10 Emanuela Gancia (1 out of 1 patent)

11 Elizabeth Anne Skidmore (1 out of 1 patent)

12 Niall Wagstaff (1 out of 1 patent)

13 Fabien Jean Ghislain Roussel (1 out of 1 patent)

14 Jason Myers (1 out of 1 patent)

15 Nadia M Ahmad (1 out of 1 patent)


7 patents:

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for schizophrenia and other central nervous system disorders. The company's lead product candidate, KarXT, aims to target muscarinic receptors to address the cognitive and negative symptoms of schizophrenia. Karuna Therapeutics is dedicated to improving the lives of patients with severe neuropsychiatric disorders through its research and development efforts.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#249 in Boston, MA

#2,243 in Massachusetts

#38,834 in US

...
Boston, MA, United States of America
Forward Citations = 9

16 inventors:

Please report any incorrect information to support@idiyas.com
Loading…